loading1
loading2

CJ America About Slide

Fort Dodge, IA January 6, 2021 – CJ BIO today announced the completion of an additional increment of threonine capacity at the company’s U.S. Fort Dodge, Iowa plant. CJ announced in August of 2020 the completion of the FDA evaluation for Thr Pro, an 80% active granular source of L-threonine, with residual biomass.

“Initial plant capacity was twenty thousand metric tons which required an investment of $50 million. Through process enhancements, additional permitting, and efficiency improvements, our team is now producing at thirty thousand metric tons per year,” commented Joe Lucas, Vice President and GM – Animal Nutrition and Health at CJ America. “Based on the commercial acceptance of Thr Pro, we are also pleased to announce approval for an additional twenty thousand metric tons of capacity, which we will bring on stream in the second quarter of 2022. We will invest another $20 million over the next eighteen months to achieve a total threonine capacity of 50 thousand metric tons. The investment will also allow CJ to begin valine production at the Fort Dodge plant,” added Lucas.

“We are committed to continue the expansion of our North America operations in the state of Iowa to optimize efficient operations and better serve customers,” added Harry Jang, Head of CJ BIO for North and South America.

CJ BIO is a division of CJ CheilJedang, a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. CJ Group has developed its business portfolio into four core sectors – Food & Food Service, Bio & Pharma, Entertainment & Media, and Retail & Logistics.

Posted in: Biotechnology

CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions

Posted on Author

CJ BIO, a division of South Korea-based CJ CheilJedang and leading producer of polyhydroxyalkanoate (PHA), and NatureWorks, an advanced materials company that is the world’s leading producer of polylactic acid (PLA), have signed a letter of intent (LOI) establishing a strategic alignment between the two organizations and have announced that the two companies are working toward a Master Collaboration Agreement (MCA). The companies will work together to develop sustainable materials solutions based on CJ BIO’s PHACT® Marine Biodegradable Polymers and NatureWorks’ Ingeo™ biomaterials technology.

More Details
Posted in: Biotechnology

CJ BIO Launches PHACT® Brand Polyhydroxyalkanoate (PHA) Product Line

Posted on Author

CJ BIO has introduced PHACT® Marine Biodegradable Polymers based on its proprietary polyhydroxyalkanoate (PHA) technology. Being a part of the solution to change the trajectory of the plastic pollution challenge and preserving the planet is the essence of the PHACT brand. PHACT means (PHA + Act) and CJ Bio is committed to impactful action delivering eco-friendly solutions with their extensive PHA technology platform.

More Details
Posted in: Biotechnology

CJ BIO Inaugurates 5,000 Metric Ton Polyhydroxyalkanoate (PHA) Facility in Pasuruan, Indonesia

Posted on Author

CJ BIO, a division of South Korea-based CJ CheilJedang, announced that it has begun manufacturing polyhydroxyalkanoate (PHA) at a newly commissioned facility located in Pasuruan, Indonesia. CJ BIO, the global leader in fermentation capacity with world-scale businesses in both animal and human nutrition, is using this new facility to enter the biomaterials sector with the goal of creating opportunities to reduce the impact of manufactured plastics on global waste streams and the environment.

More Details
Posted in: Biotechnology

CJ Bioscience eyes global microbiome market leadership

Posted on Author

CJ Bioscience, a biotechnology subsidiary of CJ CheilJedang, has been officially launched with its eyes set on becoming a global leader in the microbiome sector, the Korean food giant said Wednesday. The establishment of the biotechnology firm is part of CJ Group Chairman Lee Jay-hyun’s earlier pledge to strengthen the group’s wellness business, one of the four growth engines he had vowed to cultivate for the future.

More Details
Posted in: Biotechnology

CJ CheilJedang to launch bioscience brand

Posted on Author

The country’s No. 1 food company, CJ CheilJedang, is gearing up to introduce a new biotechnology brand next month. The brand, CJ Bioscience, will offer products and services in the field of red biotechnology involving therapeutic and pharmaceutical applications. It is part of CJ Group Chairman Lee Jay-hyun’s plan to boost its “wellness” business, which is one of the four growth engines he aims to cultivate over the next three years.

More Details
Posted in: Biotechnology

CJ BIO debuts natural cysteine ingredient

Posted on Author

CJ BIO is helping plant-based food manufacturers meet demand for clean labeling and natural ingredients with FlavorNrich, which it calls the “world’s first natural cysteine.” Cysteine is an essential ingredient for creating a meat-like flavor in animal-free products. One of 20 amino acids, it is a key precursor for creating a savory flavor through the Maillard reaction. FlavorNrich may be used to create meat-like flavors in a range of plant-based alternatives as well as broths, sauces and other animal-free applications.

More Details
Posted in: Biotechnology

CJ resumes biopharmaceutical biz

Posted on Author

The CJ Group plans to reenter the biopharmaceutical business by acquiring Chunlab three years after selling CJ Healthcare to Kolmar Korea. Chunlab, a company established in 2009 by Professor Chun Jong-sik of Seoul National University, specializes in the research and development of microbiome, a combination of microbe and biome referring to the trillions of microorganisms and their genes in the human body.

More Details
Posted in: Biotechnology

Enjoying the moment: CJ Bio America celebrates continued growth, expansion

Posted on Author

Few companies in the Fort Dodge region have experienced the type of growth seen at CJ Bio America. Nine years ago the company invested over $320 million in its Webster County plant, which produces an amino acid called lysine. Now another expansion is planned. CJ will invest about $20 million to increase production of threonine. The project, called G2, will create about 25 new jobs, bringing the total number of employees up to about 250.

More Details
1 2 3